| NCT04413552 |
INDV-2000 First in Human |
https://ClinicalTrials.gov/show/NCT04413552 |
Recruiting |
Indivior Inc. |
2020-12-01 |
| NCT03918850 |
Medication Treatment for Opioid Use Disorder in Expectant Mothers |
https://ClinicalTrials.gov/show/NCT03918850 |
Recruiting |
University of Cincinnati |
2023-12-31 |
| NCT03911466 |
Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study |
https://ClinicalTrials.gov/show/NCT03911466 |
Recruiting |
University of Cincinnati |
2023-12-31 |
| NCT03718065 |
Impact of Lofexidine on Stress, Craving and Opioid Use |
https://ClinicalTrials.gov/show/NCT03718065 |
Recruiting |
Medical University of South Carolina |
2024-04-01 |
| NCT03684681 |
The Navigator Trial |
https://ClinicalTrials.gov/show/NCT03684681 |
Recruiting |
Rhode Island Hospital |
2020-10-31 |
| NCT03396276 |
Houston Emergency Opioid Engagement System |
https://ClinicalTrials.gov/show/NCT03396276 |
Recruiting |
The University of Texas Health Science Center, Houston |
2020-11-01 |
| NCT03377855 |
Addressing Origins of the Opioid Epidemic by Improving Prescribing for Opioid-Naive Patients |
https://ClinicalTrials.gov/show/NCT03377855 |
Completed |
Weill Medical College of Cornell University |
2019-12-31 |
| NCT03368794 |
Naloxone to TReatment Entry in the Emergency Setting |
https://ClinicalTrials.gov/show/NCT03368794 |
Recruiting |
Region Skane |
2019-07-28 |
| NCT03822962 |
Pain Management Following Sinus Surgery |
https://ClinicalTrials.gov/show/NCT03822962 |
Recruiting |
University of Nebraska |
2020-12-31 |
| NCT03363243 |
Advancing STOP: Self-regulation Therapy for Opioid Addiction and Pain |
https://ClinicalTrials.gov/show/NCT03363243 |
Recruiting |
University of Colorado, Denver |
2021-03-31 |
| NCT03345173 |
Facilitating Rapid Naltrexone Initiation |
https://ClinicalTrials.gov/show/NCT03345173 |
Recruiting |
New York State Psychiatric Institute |
2021-10-31 |
| NCT03334903 |
Gabapentin Regimens and Their Effects on Opioid Consumption |
https://ClinicalTrials.gov/show/NCT03334903 |
Completed |
Brigham and Women’s Hospital |
2019-04-24 |
| NCT03320889 |
Hepatitis C Education for Pregnant Women With Opiate Dependence - Phase 2 |
https://ClinicalTrials.gov/show/NCT03320889 |
Completed |
TriHealth Inc. |
2019-08-26 |
| NCT03306368 |
Youth Opioid Recovery Support: A Developmentally-specific Intervention for Home Delivery of Extended Release Naltrexone |
https://ClinicalTrials.gov/show/NCT03306368 |
Completed |
Potomac Health Foundations |
2019-06-01 |
| NCT03305666 |
Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures |
https://ClinicalTrials.gov/show/NCT03305666 |
Recruiting |
Denver Health and Hospital Authority |
2020-04-30 |
| NCT03287180 |
Adolescent Community Reinforcement Approach in Combination With Buprenorphine/Naloxone for Severe Opioid Use |
https://ClinicalTrials.gov/show/NCT03287180 |
Recruiting |
Emory University |
2020-08-30 |
| NCT03278496 |
Recovery Housing and Drug Abuse Treatment Outcome |
https://ClinicalTrials.gov/show/NCT03278496 |
Completed |
Johns Hopkins University |
2008-06-30 |
| NCT03235154 |
A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic |
https://ClinicalTrials.gov/show/NCT03235154 |
Active, not recruiting |
Community Research Initiative of New England |
2020-04-30 |
| NCT03190954 |
Brain Dopaminergic Signaling in Opioid Use Disorders |
https://ClinicalTrials.gov/show/NCT03190954 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2024-12-31 |
| NCT03150173 |
Onsite Buprenorphine Treatment at Syringe Exchange Programs |
https://ClinicalTrials.gov/show/NCT03150173 |
Recruiting |
Montefiore Medical Center |
2021-06-30 |
| NCT03143855 |
Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder |
https://ClinicalTrials.gov/show/NCT03143855 |
Completed |
Virginia Commonwealth University |
2019-04-05 |
| NCT03134092 |
The Life STORRIED Study |
https://ClinicalTrials.gov/show/NCT03134092 |
Completed |
University of Pennsylvania |
2019-08-07 |
| NCT03129347 |
Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT03129347 |
Completed |
National Institute on Drug Abuse (NIDA) |
2017-06-09 |
| NCT03089983 |
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings |
https://ClinicalTrials.gov/show/NCT03089983 |
Recruiting |
Yale University |
2022-04-30 |
| NCT03048643 |
Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis |
https://ClinicalTrials.gov/show/NCT03048643 |
Completed |
University of Kentucky |
2018-10-02 |
| NCT03015597 |
Pilot Study of Contingency Management for Smoking Cessation |
https://ClinicalTrials.gov/show/NCT03015597 |
Completed |
King’s College London |
2017-09-30 |
| NCT02997644 |
Impact of Different Educational Approaches on Post-operative Opiate Utilization After Elective Lower Extremity Surgery |
https://ClinicalTrials.gov/show/NCT02997644 |
Completed |
Brooke Army Medical Center |
2019-04-30 |
| NCT02978417 |
Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court Settings |
https://ClinicalTrials.gov/show/NCT02978417 |
Completed |
Duke University |
2019-06-30 |
| NCT02922959 |
A Tailored, Peer-delivered Intervention to Reduce Recurring Opioid Overdoses |
https://ClinicalTrials.gov/show/NCT02922959 |
Completed |
University of Cincinnati |
2019-07-25 |
| NCT02896296 |
Open-Label Treatment Extension Study |
https://ClinicalTrials.gov/show/NCT02896296 |
Completed |
Indivior Inc. |
2017-08-23 |
| NCT02867124 |
Long-acting Naltrexone for Pre-release Prisoners |
https://ClinicalTrials.gov/show/NCT02867124 |
Recruiting |
Friends Research Institute, Inc. |
2020-08-31 |
| NCT02804152 |
Program for Pain & Prescription Opioid Use in Pregnancy |
https://ClinicalTrials.gov/show/NCT02804152 |
Active, not recruiting |
Medical University of South Carolina |
2019-01-31 |
| NCT02801357 |
Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction |
https://ClinicalTrials.gov/show/NCT02801357 |
Completed |
US WorldMeds LLC |
2016-08-31 |
| NCT02774954 |
Change the Cycle: An RCT to Prevent Injection Initiation |
https://ClinicalTrials.gov/show/NCT02774954 |
Active, not recruiting |
University of Southern California |
2018-12-31 |
| NCT02750748 |
Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT02750748 |
Completed |
National Institute on Drug Abuse (NIDA) |
2016-09-30 |
| NCT02696096 |
Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence |
https://ClinicalTrials.gov/show/NCT02696096 |
Completed |
Butler Hospital |
2020-02-29 |
| NCT02674711 |
Study of Opioid Use After Lumbar and Cervical Spine Surgery |
https://ClinicalTrials.gov/show/NCT02674711 |
Completed |
Brooke Army Medical Center |
2017-02-28 |
| NCT02616523 |
Influence of Dexmedetomidine and Lidocaine on Opioid Consumption in Laparoscopic Intestine Resection |
https://ClinicalTrials.gov/show/NCT02616523 |
Completed |
University Medical Centre Ljubljana |
2015-06-30 |
| NCT02602795 |
Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence |
https://ClinicalTrials.gov/show/NCT02602795 |
Completed |
Rhode Island Hospital |
2018-01-31 |
| NCT02593474 |
Medication-Assisted Treatment for Youth With Substance Use Disorders |
https://ClinicalTrials.gov/show/NCT02593474 |
Completed |
New York State Psychiatric Institute |
2018-04-30 |
| NCT02586896 |
Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments |
https://ClinicalTrials.gov/show/NCT02586896 |
Completed |
NYU Langone Health |
2019-04-23 |
| NCT03098407 |
Opioid Dependence Treatment Therapies in Pregnancy |
https://ClinicalTrials.gov/show/NCT03098407 |
Active, not recruiting |
University of Pittsburgh |
2019-10-09 |
| NCT02526212 |
Buprenorphine Group Medical Visits in Primary Care |
https://ClinicalTrials.gov/show/NCT02526212 |
Completed |
Montefiore Medical Center |
2019-05-31 |
| NCT02572089 |
Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT02572089 |
Completed |
National Institute on Drug Abuse (NIDA) |
2015-01-31 |
| NCT00000319 |
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2 |
https://ClinicalTrials.gov/show/NCT00000319 |
Completed |
Yale University |
NA |
| NCT03389750 |
A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists. |
https://ClinicalTrials.gov/show/NCT03389750 |
Recruiting |
New York State Psychiatric Institute |
2020-12-31 |
| NCT00023283 |
Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1 |
https://ClinicalTrials.gov/show/NCT00023283 |
Completed |
Yale University |
2003-12-31 |
| NCT02548728 |
Oxytocin Treatment of Opioid Dependence |
https://ClinicalTrials.gov/show/NCT02548728 |
Completed |
University of North Carolina, Chapel Hill |
2016-12-31 |
| NCT00000216 |
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1 |
https://ClinicalTrials.gov/show/NCT00000216 |
Completed |
Yale University |
NA |
| NCT02543944 |
Improving Treatment Outcomes for Prescription Opioid Dependence |
https://ClinicalTrials.gov/show/NCT02543944 |
Recruiting |
University of Arkansas |
2020-06-30 |
| NCT02539823 |
Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans |
https://ClinicalTrials.gov/show/NCT02539823 |
Completed |
Hurd,Yasmin, Ph.D. |
2017-05-24 |
| NCT02510014 |
Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder |
https://ClinicalTrials.gov/show/NCT02510014 |
Completed |
Indivior Inc. |
2017-01-31 |
| NCT02502175 |
Comparing Opium Tincture (OT) With Methadone for Medication-assisted Treatment of Opioid Use Disorder |
https://ClinicalTrials.gov/show/NCT02502175 |
Completed |
University of British Columbia |
2018-03-08 |
| NCT02496403 |
Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence |
https://ClinicalTrials.gov/show/NCT02496403 |
Completed |
Kaiser Permanente |
2019-05-31 |
| NCT02477267 |
Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT02477267 |
Completed |
INSYS Therapeutics Inc |
2015-07-31 |
| NCT02440152 |
The Effectiveness of Deep Brain Stimulation for Opioid Relapse Prevention |
https://ClinicalTrials.gov/show/NCT02440152 |
Recruiting |
Ruijin Hospital |
2019-07-31 |
| NCT02437344 |
Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence |
https://ClinicalTrials.gov/show/NCT02437344 |
Completed |
New York State Psychiatric Institute |
2016-12-31 |
| NCT02411357 |
Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II |
https://ClinicalTrials.gov/show/NCT02411357 |
Active, not recruiting |
University of Vermont |
2019-03-06 |
| NCT02396979 |
Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia |
https://ClinicalTrials.gov/show/NCT02396979 |
Completed |
Yale University |
2014-12-31 |
| NCT02372591 |
Study of the Treatment of Experimental Pain in Buprenorphine Maintained Persons With Chronic Musculoskeletal Pain |
https://ClinicalTrials.gov/show/NCT02372591 |
Completed |
Johns Hopkins University |
2017-06-30 |
| NCT02362256 |
The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid Antagonism |
https://ClinicalTrials.gov/show/NCT02362256 |
Completed |
Vilnius University |
2014-06-30 |
| NCT02360007 |
Interim Buprenorphine: Leveraging Medication + Technology to Bridge Delays in Treatment Access |
https://ClinicalTrials.gov/show/NCT02360007 |
Completed |
University of Vermont Medical Center |
2016-06-30 |
| NCT02359006 |
The Effects of Minocycline in Opioid-maintained Patients |
https://ClinicalTrials.gov/show/NCT02359006 |
Completed |
Yale University |
2017-04-19 |
| NCT02357901 |
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine |
https://ClinicalTrials.gov/show/NCT02357901 |
Completed |
Indivior Inc. |
2016-04-29 |
| NCT02345655 |
On-site Evaluation of Substances Consumption on Opiate Maintenance |
https://ClinicalTrials.gov/show/NCT02345655 |
Recruiting |
University Hospital, Toulouse |
2020-04-30 |
| NCT02324725 |
Biomarkers of Injectable Extended Release Naltrexone Treatment |
https://ClinicalTrials.gov/show/NCT02324725 |
Active, not recruiting |
University of Pennsylvania |
2021-10-31 |
| NCT02294253 |
Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone |
https://ClinicalTrials.gov/show/NCT02294253 |
Completed |
New York State Psychiatric Institute |
2017-12-31 |
| NCT02282306 |
Phone Interview to Prevent Recurring Opioid Overdoses |
https://ClinicalTrials.gov/show/NCT02282306 |
Completed |
University of Cincinnati |
2015-02-28 |
| NCT02252068 |
Study of Treatment for Opioid Dependence and Anxiety Disorders |
https://ClinicalTrials.gov/show/NCT02252068 |
Completed |
Mclean Hospital |
2019-10-24 |
| NCT02243670 |
Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy |
https://ClinicalTrials.gov/show/NCT02243670 |
Completed |
AiCure |
2017-03-31 |
| NCT02200406 |
Desvenlafaxine in Opioid-Dependent Patients |
https://ClinicalTrials.gov/show/NCT02200406 |
Completed |
Centre hospitalier de l’Université de Montréal (CHUM) |
2017-01-31 |
| NCT02187198 |
Buprenorphine Treatment for Opioid Dependence |
https://ClinicalTrials.gov/show/NCT02187198 |
Active, not recruiting |
Yale University |
2021-02-01 |
| NCT02180659 |
A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants |
https://ClinicalTrials.gov/show/NCT02180659 |
Completed |
Titan Pharmaceuticals |
2015-05-31 |
| NCT02152397 |
Safety and Health Intervention Project |
https://ClinicalTrials.gov/show/NCT02152397 |
Completed |
University of Michigan |
2016-12-31 |
| NCT02093559 |
Repeated-dose Brief Intervention to Reduce Overdose and Risk Behaviors Among Naloxone Recipients |
https://ClinicalTrials.gov/show/NCT02093559 |
Completed |
San Francisco Department of Public Health |
2016-12-31 |
| NCT01315184 |
Study of Computer-Based Treatment for Drug Dependence |
https://ClinicalTrials.gov/show/NCT01315184 |
Completed |
Yale University |
2011-07-31 |
| NCT01311778 |
Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse |
https://ClinicalTrials.gov/show/NCT01311778 |
Completed |
Hurd,Yasmin, Ph.D. |
2011-10-31 |
| NCT01275599 |
Drug-Drug Interaction Study Between Telaprevir and Buprenorphine |
https://ClinicalTrials.gov/show/NCT01275599 |
Completed |
Vertex Pharmaceuticals Incorporated |
2011-04-30 |
| NCT02038790 |
Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population |
https://ClinicalTrials.gov/show/NCT02038790 |
Completed |
Indivior Inc. |
2013-11-30 |
| NCT04454645 |
Intervening With Opioid-Dependent MothersMothers and Infants |
https://ClinicalTrials.gov/show/NCT04454645 |
Recruiting |
University of Delaware |
2025-03-31 |
| NCT01999946 |
Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry |
https://ClinicalTrials.gov/show/NCT01999946 |
Active, not recruiting |
NYU Langone Health |
2019-05-28 |
| NCT01967641 |
Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse |
https://ClinicalTrials.gov/show/NCT01967641 |
Completed |
New York State Psychiatric Institute |
2011-06-30 |
| NCT01965704 |
Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women |
https://ClinicalTrials.gov/show/NCT01965704 |
Recruiting |
Stanford University |
2021-03-30 |
| NCT01913418 |
Clinical Efficacy and Serum Proteomic Profiling of Suan-Zao-Ren Tang for Sleep Disturbance During Methadone Maintenance |
https://ClinicalTrials.gov/show/NCT01913418 |
Completed |
China Medical University, Taiwan |
2014-03-31 |
| NCT01909076 |
Transforming Opioid Prescribing in Primary Care |
https://ClinicalTrials.gov/show/NCT01909076 |
Completed |
Boston Medical Center |
2016-03-31 |
| NCT01908842 |
Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults |
https://ClinicalTrials.gov/show/NCT01908842 |
Completed |
Orexo AB |
2014-04-30 |
| NCT01903005 |
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence |
https://ClinicalTrials.gov/show/NCT01903005 |
Completed |
Orexo AB |
2014-09-30 |
| NCT01895270 |
Improving Buprenorphine Detoxification Outcomes With Isradipine |
https://ClinicalTrials.gov/show/NCT01895270 |
Completed |
University of Arkansas |
2016-04-30 |
| NCT01895036 |
Nalrexone Facilitated Discontinuation of Buprenorphine |
https://ClinicalTrials.gov/show/NCT01895036 |
Completed |
New York State Psychiatric Institute |
2013-09-30 |
| NCT01894087 |
Safety & Prevention Outcomes Study |
https://ClinicalTrials.gov/show/NCT01894087 |
Completed |
University of Michigan |
2015-01-31 |
| NCT01882361 |
Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone |
https://ClinicalTrials.gov/show/NCT01882361 |
Active, not recruiting |
University of Pennsylvania |
2020-07-31 |
| NCT01880086 |
Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration |
https://ClinicalTrials.gov/show/NCT01880086 |
Completed |
Weill Medical College of Cornell University |
2016-03-31 |
| NCT01873989 |
Testosterone Replacement for Male Opioid Agonist Maintained Patients |
https://ClinicalTrials.gov/show/NCT01873989 |
Completed |
Yale University |
2015-01-31 |
| NCT01863251 |
Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia |
https://ClinicalTrials.gov/show/NCT01863251 |
Completed |
Yale University |
2014-08-31 |
| NCT01863186 |
Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal |
https://ClinicalTrials.gov/show/NCT01863186 |
Completed |
US WorldMeds LLC |
2014-11-30 |
| NCT01848054 |
Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence |
https://ClinicalTrials.gov/show/NCT01848054 |
Completed |
Orexo AB |
2014-01-31 |
| NCT01846481 |
A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse |
https://ClinicalTrials.gov/show/NCT01846481 |
Completed |
Indivior Inc. |
2013-06-30 |
| NCT01843751 |
Dane County Drug Court Study for Addicted Offenders |
https://ClinicalTrials.gov/show/NCT01843751 |
Completed |
University of Wisconsin, Madison |
2016-02-29 |
| NCT01820442 |
Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients |
https://ClinicalTrials.gov/show/NCT01820442 |
Completed |
US WorldMeds LLC |
2013-09-30 |
| NCT01779973 |
Remote Observed Dosing to Increase Suboxone Compliance |
https://ClinicalTrials.gov/show/NCT01779973 |
Completed |
University of Pennsylvania |
2013-09-30 |
| NCT01761110 |
Pilot Test of a Community-based Buprenorphine Treatment Intervention |
https://ClinicalTrials.gov/show/NCT01761110 |
Completed |
Albert Einstein College of Medicine |
2014-02-28 |
| NCT01759446 |
Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users |
https://ClinicalTrials.gov/show/NCT01759446 |
Completed |
Acura Pharmaceuticals Inc. |
2013-04-30 |
| NCT01741350 |
Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users |
https://ClinicalTrials.gov/show/NCT01741350 |
Completed |
University of Connecticut |
2011-05-31 |
| NCT01740414 |
Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers |
https://ClinicalTrials.gov/show/NCT01740414 |
Completed |
New York State Psychiatric Institute |
2015-12-31 |
| NCT01738503 |
Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects |
https://ClinicalTrials.gov/show/NCT01738503 |
Completed |
Indivior Inc. |
2014-05-31 |
| NCT01733693 |
Neurocognitive Effects of Opiate Agonist Treatment |
https://ClinicalTrials.gov/show/NCT01733693 |
Completed |
Albert Einstein College of Medicine |
2017-06-30 |
| NCT01728909 |
Methadone Oxytocin Option |
https://ClinicalTrials.gov/show/NCT01728909 |
Completed |
University of California, San Francisco |
2014-10-31 |
| NCT01718964 |
Acute Effects of Cortisol on Heroin Craving in Opioid Dependence (Ghost-Basel) |
https://ClinicalTrials.gov/show/NCT01718964 |
Completed |
University of Basel |
2013-07-31 |
| NCT01717963 |
Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway |
https://ClinicalTrials.gov/show/NCT01717963 |
Completed |
University of Oslo |
2016-08-31 |
| NCT01690546 |
Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence |
https://ClinicalTrials.gov/show/NCT01690546 |
Completed |
Duke University |
2015-02-28 |
| NCT01666119 |
An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects |
https://ClinicalTrials.gov/show/NCT01666119 |
Completed |
BioDelivery Sciences International |
2013-01-31 |
| NCT01650649 |
Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients |
https://ClinicalTrials.gov/show/NCT01650649 |
Completed |
US WorldMeds LLC |
2012-12-31 |
| NCT01645033 |
Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients |
https://ClinicalTrials.gov/show/NCT01645033 |
Completed |
Yale University |
2013-12-31 |
| NCT01642030 |
Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance |
https://ClinicalTrials.gov/show/NCT01642030 |
Completed |
Johns Hopkins University |
2017-07-31 |
| NCT01605539 |
Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans |
https://ClinicalTrials.gov/show/NCT01605539 |
Completed |
Hurd,Yasmin, Ph.D. |
2013-10-31 |
| NCT01595867 |
Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo |
https://ClinicalTrials.gov/show/NCT01595867 |
Completed |
Pfizer |
2011-01-31 |
| NCT01590251 |
Yoga for Pain and Opioid Dependence |
https://ClinicalTrials.gov/show/NCT01590251 |
Completed |
Yale University |
2014-11-30 |
| NCT01582347 |
Transfer of Subjects From Subutex/Suboxone to RBP-6300 |
https://ClinicalTrials.gov/show/NCT01582347 |
Completed |
Indivior Inc. |
2012-11-30 |
| NCT01558934 |
Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients |
https://ClinicalTrials.gov/show/NCT01558934 |
Completed |
US WorldMeds LLC |
2012-04-30 |
| NCT01556425 |
The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid Dependence |
https://ClinicalTrials.gov/show/NCT01556425 |
Completed |
Johns Hopkins University |
2016-12-12 |
| NCT01556087 |
Distress Tolerance and Buprenorphine |
https://ClinicalTrials.gov/show/NCT01556087 |
Completed |
Butler Hospital |
2014-02-28 |
| NCT01530542 |
A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01530542 |
Completed |
Pfizer |
2010-09-30 |
| NCT01527994 |
Aprepitant Effects in Intravenous Heroin Dependence |
https://ClinicalTrials.gov/show/NCT01527994 |
Completed |
New York University |
2014-06-30 |
| NCT01512433 |
The Clinical Efficacy of Acupuncture as an Adjunct to Methadone Treatment Services for Heroin Addicts |
https://ClinicalTrials.gov/show/NCT01512433 |
Completed |
China Medical University, Taiwan |
2012-03-31 |
| NCT01505101 |
Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy |
https://ClinicalTrials.gov/show/NCT01505101 |
Completed |
Florida State University |
2013-07-31 |
| NCT01471145 |
Depot Naltrexone Mechanism of Action in Heroin Dependent Patients Using fMRI and SPECT |
https://ClinicalTrials.gov/show/NCT01471145 |
Completed |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2014-10-31 |
| NCT01453374 |
A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration |
https://ClinicalTrials.gov/show/NCT01453374 |
Completed |
Alkermes, Inc. |
2014-05-31 |
| NCT01447212 |
Study to Assess Longer-term Opioid Medication Effectiveness (SALOME) |
https://ClinicalTrials.gov/show/NCT01447212 |
Completed |
University of British Columbia |
2014-06-30 |
| NCT01442493 |
Reengineering Methadone Treatment Study of Patient-centered Methadone Treatment |
https://ClinicalTrials.gov/show/NCT01442493 |
Completed |
Friends Research Institute, Inc. |
2015-04-30 |
| NCT01425060 |
Improving Effective Contraceptive Use Among Opioid-maintained Women |
https://ClinicalTrials.gov/show/NCT01425060 |
Completed |
University of Vermont |
2014-06-30 |
| NCT01416584 |
A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment |
https://ClinicalTrials.gov/show/NCT01416584 |
Completed |
Johns Hopkins University |
2013-10-31 |
| NCT01395784 |
Effects of Pioglitazone, a PPARgamma Receptor Agonist, on the Abuse Liability of Oxycodone |
https://ClinicalTrials.gov/show/NCT01395784 |
Completed |
New York State Psychiatric Institute |
2014-01-31 |
| NCT01393392 |
Developing a Smoking Cessation Intervention for Methadone Maintained Smokers |
https://ClinicalTrials.gov/show/NCT01393392 |
Completed |
Rutgers, The State University of New Jersey |
2014-05-31 |
| NCT01389180 |
Behavioral Drug and HIV Risk Reduction Counseling With MMT in China |
https://ClinicalTrials.gov/show/NCT01389180 |
Completed |
Yale University |
2016-06-30 |
| NCT01380093 |
Abuse Potential of Orally Administered Crushed Embeda Compared to Crushed Controlled-Release Morphine and Placebo in Non-Dependent Recreational Opioid Users |
https://ClinicalTrials.gov/show/NCT01380093 |
Completed |
Pfizer |
2011-05-31 |
| NCT01377610 |
Improved Strategies for Outpatient Opioid Detoxification |
https://ClinicalTrials.gov/show/NCT01377610 |
Completed |
New York State Psychiatric Institute |
2017-12-31 |
| NCT01376570 |
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment |
https://ClinicalTrials.gov/show/NCT01376570 |
Completed |
Albert Einstein College of Medicine |
2017-08-10 |
| NCT01374763 |
A Comparison of PR Oxycodone/Naloxone and PR Oxycodone After Cardiac Surgery |
https://ClinicalTrials.gov/show/NCT01374763 |
Completed |
Tampere University Hospital |
2011-12-31 |
| NCT01344122 |
Medication-Assisted Treatment Implementation in Community Correctional Environments (MATICCE) |
https://ClinicalTrials.gov/show/NCT01344122 |
Completed |
Rhode Island Hospital |
2013-09-30 |
| NCT01334580 |
Cognitive-Behavioral Therapy for Pain and Opioid Dependence in Methadone Maintenance Treatment |
https://ClinicalTrials.gov/show/NCT01334580 |
Completed |
Yale University |
2014-09-30 |
| NCT04340622 |
Efficacy And Safety Of An Innovative Treatment Of Opiate Use Disorders |
https://ClinicalTrials.gov/show/NCT04340622 |
Recruiting |
MindLight, LLC |
2020-12-15 |
| NCT04272671 |
De-prescribing Program to Evaluate Falls in Older Adults |
https://ClinicalTrials.gov/show/NCT04272671 |
Recruiting |
University of North Carolina, Chapel Hill |
2021-09-30 |
| NCT04220489 |
Perioperative Ketamine in Opioid-Tolerant Patients Undergoing Lumbar Spine Surgery |
https://ClinicalTrials.gov/show/NCT04220489 |
Recruiting |
University of Pittsburgh |
2020-06-30 |
| NCT04189523 |
Does Early Administration of Ultrasound Guided Regional Anesthesia for Long Bone Fractures Effect Long Term Patient Opioid Usage |
https://ClinicalTrials.gov/show/NCT04189523 |
Recruiting |
Wayne State University |
2020-06-30 |
| NCT04080037 |
Assessing Opioid Care Practices Using CPV Patient Simulation Modules |
https://ClinicalTrials.gov/show/NCT04080037 |
Completed |
Qure Healthcare, LLC |
2019-10-29 |
| NCT04033562 |
The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis |
https://ClinicalTrials.gov/show/NCT04033562 |
Recruiting |
WellSpan Health |
2021-09-01 |
| NCT04018664 |
Oral Abuse Potential Study of Nalbuphine |
https://ClinicalTrials.gov/show/NCT04018664 |
Completed |
Trevi Therapeutics |
2018-12-03 |
| NCT04015115 |
Youth Opioid Recovery Support: Improving Care Systems |
https://ClinicalTrials.gov/show/NCT04015115 |
Active, not recruiting |
University of Maryland, Baltimore |
2020-05-31 |
| NCT03992079 |
A Multimodal Enhanced Recovery Program in Anorectal Surgery |
https://ClinicalTrials.gov/show/NCT03992079 |
Recruiting |
Columbia University |
2020-07-31 |
| NCT03971097 |
The Effect of Self-Forgiveness on Self-Stigma in Addiction. |
https://ClinicalTrials.gov/show/NCT03971097 |
Completed |
University of Pittsburgh |
2019-12-01 |
| NCT03950492 |
Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder |
https://ClinicalTrials.gov/show/NCT03950492 |
Recruiting |
West Virginia University |
2020-12-30 |
| NCT03949764 |
The Kentucky Viral Hepatitis Treatment Study |
https://ClinicalTrials.gov/show/NCT03949764 |
Recruiting |
University of Kentucky |
2022-08-31 |
| NCT03842137 |
tDCS to Decrease Opioid Relapse |
https://ClinicalTrials.gov/show/NCT03842137 |
Recruiting |
Butler Hospital |
2023-12-31 |
| NCT03838510 |
Repeated-dose Behavioral Intervention to Reduce Opioid Overdose |
https://ClinicalTrials.gov/show/NCT03838510 |
Recruiting |
San Francisco Department of Public Health |
2022-12-31 |
| NCT03837860 |
Reducing the Abuse of Opioids in Drug Users |
https://ClinicalTrials.gov/show/NCT03837860 |
Recruiting |
The University of Texas Health Science Center at San Antonio |
2021-03-31 |
| NCT03834025 |
Nudges and Incentives to Enhance the Opioid Treatment Workforce |
https://ClinicalTrials.gov/show/NCT03834025 |
Active, not recruiting |
University of North Carolina, Chapel Hill |
2020-08-28 |
| NCT03831113 |
Pharmacologically-based Strategies for Buprenorphine Treatment During Pregnancy |
https://ClinicalTrials.gov/show/NCT03831113 |
Recruiting |
University of Pittsburgh |
2023-05-31 |
| NCT03809143 |
Community Studies of Long Acting Buprenorphine (CoLAB) |
https://ClinicalTrials.gov/show/NCT03809143 |
Active, not recruiting |
The University of New South Wales |
2020-11-01 |
| NCT03798470 |
FAVOR Opioid Recovery Coaching Evaluation |
https://ClinicalTrials.gov/show/NCT03798470 |
Completed |
Prisma Health-Upstate |
2018-12-31 |
| NCT03791645 |
Evaluating The Efficacy Of A Mind-Body Intervention In Overcoming Opioid Addiction |
https://ClinicalTrials.gov/show/NCT03791645 |
Recruiting |
Ohio State University |
2020-12-30 |
| NCT03789214 |
Medical Management of Sleep Disturbance During Opioid Tapering |
https://ClinicalTrials.gov/show/NCT03789214 |
Recruiting |
Johns Hopkins University |
2021-07-31 |
| NCT03783702 |
Pain Control Following Sinus Surgery |
https://ClinicalTrials.gov/show/NCT03783702 |
Recruiting |
Stanford University |
2019-10-01 |
| NCT03779997 |
Trial of Adherence App for Buprenorphine Treatment (TAAB) Study |
https://ClinicalTrials.gov/show/NCT03779997 |
Active, not recruiting |
University of Washington |
2020-05-15 |
| NCT03773523 |
Neuromodulation and Cognitive Training in Opioid Use Disorder |
https://ClinicalTrials.gov/show/NCT03773523 |
Recruiting |
University of Minnesota |
2021-10-31 |
| NCT03769025 |
Remote Observed Dosing of Suboxone to Improve Clinical Practice |
https://ClinicalTrials.gov/show/NCT03769025 |
Active, not recruiting |
University of Pennsylvania |
2022-12-31 |
| NCT03681769 |
Developing Brain Stimulation as a Treatment for Chronic Pain in Opiate Dependent |
https://ClinicalTrials.gov/show/NCT03681769 |
Recruiting |
Medical University of South Carolina |
2021-07-31 |
| NCT03675386 |
Reducing Opioid Use for Chronic Pain Patients Following Surgery |
https://ClinicalTrials.gov/show/NCT03675386 |
Recruiting |
University Health Network, Toronto |
2020-09-30 |
| NCT03662529 |
Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting |
https://ClinicalTrials.gov/show/NCT03662529 |
Completed |
Hunter Holmes Mcguire Veteran Affairs Medical Center |
2018-01-08 |
| NCT03647774 |
Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery |
https://ClinicalTrials.gov/show/NCT03647774 |
Recruiting |
University Hospital, Akershus |
2023-08-31 |
| NCT03604159 |
XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept |
https://ClinicalTrials.gov/show/NCT03604159 |
Recruiting |
NYU Langone Health |
2020-06-30 |
| NCT03576781 |
Developing rTMS Treatment Strategies for Pain in Opiate Dependence |
https://ClinicalTrials.gov/show/NCT03576781 |
Completed |
Medical University of South Carolina |
2019-11-12 |
| NCT03575273 |
The Impact of Methadone Maintenance Therapy on Food Reward Processing in Opioid Dependence |
https://ClinicalTrials.gov/show/NCT03575273 |
Active, not recruiting |
Johns Hopkins University |
2019-12-01 |
| NCT03567356 |
Treatment of Opioid Use: Medication Adherence Therapy |
https://ClinicalTrials.gov/show/NCT03567356 |
Recruiting |
Potomac Health Foundations |
2020-09-30 |
| NCT03549312 |
Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy |
https://ClinicalTrials.gov/show/NCT03549312 |
Recruiting |
Saskatchewan Health Authority - Regina Area |
2020-07-21 |
| NCT03526380 |
The OPT-IN Project |
https://ClinicalTrials.gov/show/NCT03526380 |
Active, not recruiting |
University of Michigan |
2020-06-30 |
| NCT03521960 |
Buspirone for Opioid Tapering |
https://ClinicalTrials.gov/show/NCT03521960 |
Recruiting |
Johns Hopkins University |
2020-05-30 |
| NCT03475862 |
Nasal Human Abuse Potential of PTI-821 |
https://ClinicalTrials.gov/show/NCT03475862 |
Completed |
PainT |
2017-07-31 |
| NCT03447743 |
Re-entry XR-NTX for Rural Women With Opioid Use Disorder |
https://ClinicalTrials.gov/show/NCT03447743 |
Recruiting |
University of Kentucky |
2021-03-31 |
| NCT03411265 |
RETAIN: Retaining Opioid Users Entering Medication Assisted Treatment and Encouraging HCV/HIV Testing |
https://ClinicalTrials.gov/show/NCT03411265 |
Completed |
University of Cincinnati |
2018-09-06 |
| NCT01262261 |
Re-Treatment Study of Probuphine in Opioid Addiction |
https://ClinicalTrials.gov/show/NCT01262261 |
Completed |
Titan Pharmaceuticals |
2011-11-30 |
| NCT01262092 |
Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals |
https://ClinicalTrials.gov/show/NCT01262092 |
Completed |
University of Arkansas |
2011-12-31 |
| NCT01246401 |
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations |
https://ClinicalTrials.gov/show/NCT01246401 |
Completed |
Yale University |
2016-03-31 |
| NCT01218984 |
ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids |
https://ClinicalTrials.gov/show/NCT01218984 |
Completed |
Alkermes, Inc. |
2003-05-31 |
| NCT01188421 |
Medications Development for Drug Abuse Disorders |
https://ClinicalTrials.gov/show/NCT01188421 |
Completed |
Johns Hopkins University |
2015-06-30 |
| NCT01182402 |
Electronic Compliance Monitoring in Opioid Substitution Treatment |
https://ClinicalTrials.gov/show/NCT01182402 |
Completed |
Kuopio University Hospital |
2011-02-28 |
| NCT01180647 |
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail |
https://ClinicalTrials.gov/show/NCT01180647 |
Completed |
NYU Langone Health |
2013-07-31 |
| NCT01136356 |
A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals |
https://ClinicalTrials.gov/show/NCT01136356 |
Completed |
Johns Hopkins University |
2012-03-31 |
| NCT01114308 |
A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction |
https://ClinicalTrials.gov/show/NCT01114308 |
Completed |
Titan Pharmaceuticals |
2011-05-31 |
| NCT01082679 |
Treatment for Opioid Dependent Offenders |
https://ClinicalTrials.gov/show/NCT01082679 |
Completed |
University of Wisconsin, Madison |
2011-03-31 |
| NCT01052662 |
Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults |
https://ClinicalTrials.gov/show/NCT01052662 |
Completed |
University of Massachusetts, Worcester |
2013-06-30 |
| NCT01045278 |
Hepatitis C in a Cohort of Patients With Maintenance Therapy for Opiate Dependence - Prevalence, Severity and Outcome of Antiviral Therapy |
https://ClinicalTrials.gov/show/NCT01045278 |
Completed |
Region Skane |
2013-09-30 |
| NCT01030406 |
Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid Users |
https://ClinicalTrials.gov/show/NCT01030406 |
Completed |
Acura Pharmaceuticals Inc. |
2010-02-28 |
| NCT01024335 |
Dronabinol Naltrexone Treatment for Opioid Dependence |
https://ClinicalTrials.gov/show/NCT01024335 |
Completed |
New York State Psychiatric Institute |
2012-12-31 |
| NCT01004393 |
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients |
https://ClinicalTrials.gov/show/NCT01004393 |
Completed |
University of Vermont |
2013-12-31 |
| NCT00999544 |
Aprepitant Effects on Oxycodone Response |
https://ClinicalTrials.gov/show/NCT00999544 |
Completed |
University of Kentucky |
2011-04-30 |
| NCT00992095 |
Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions |
https://ClinicalTrials.gov/show/NCT00992095 |
Completed |
West-Ward Pharmaceutical |
2006-09-30 |
| NCT00987961 |
Linking Hospitalized Injection Drug Users to Buprenorphine |
https://ClinicalTrials.gov/show/NCT00987961 |
Completed |
Butler Hospital |
2014-03-31 |
| NCT00929253 |
Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II) |
https://ClinicalTrials.gov/show/NCT00929253 |
Completed |
Virginia Polytechnic Institute and State University |
2010-04-30 |
| NCT00913770 |
Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department |
https://ClinicalTrials.gov/show/NCT00913770 |
Completed |
Yale University |
2013-08-31 |
| NCT00901875 |
Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan |
https://ClinicalTrials.gov/show/NCT00901875 |
Completed |
Indivior Inc. |
2009-11-30 |
| NCT00879996 |
Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients |
https://ClinicalTrials.gov/show/NCT00879996 |
Completed |
State University of New York at Buffalo |
2011-10-31 |
| NCT00842036 |
CRAFT Behavior Therapy: Treatment Entry Component |
https://ClinicalTrials.gov/show/NCT00842036 |
Completed |
Treatment Research Institute |
2009-12-31 |
| NCT03241771 |
Impact of Direct Outreach to Expand Access to Naloxone in the Context of Standing Orders |
https://ClinicalTrials.gov/show/NCT03241771 |
Active, not recruiting |
Kaiser Permanente |
2018-08-14 |
| NCT00834080 |
ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals |
https://ClinicalTrials.gov/show/NCT00834080 |
Completed |
Alkermes, Inc. |
2012-05-31 |
| NCT00829777 |
Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects |
https://ClinicalTrials.gov/show/NCT00829777 |
Completed |
California Pacific Medical Center Research Institute |
2009-09-30 |
| NCT01550341 |
HIV, Buprenorphine, and the Criminal Justice System |
https://ClinicalTrials.gov/show/NCT01550341 |
Completed |
Yale University |
2015-11-30 |
| NCT01436474 |
Pilot Study of Varenicline to Treat Opioid Dependence |
https://ClinicalTrials.gov/show/NCT01436474 |
Completed |
Mayo Clinic |
2012-09-30 |
| NCT01389167 |
Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia |
https://ClinicalTrials.gov/show/NCT01389167 |
Completed |
Yale University |
2016-09-30 |
| NCT04156802 |
Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain |
https://ClinicalTrials.gov/show/NCT04156802 |
Recruiting |
Wake Forest University Health Sciences |
2021-12-31 |
| NCT03891628 |
Modified ABC: A Home-based Parenting Program for Opioid-dependent Mothers and Their Infants |
https://ClinicalTrials.gov/show/NCT03891628 |
Recruiting |
University of Delaware |
2025-03-31 |
| NCT03538444 |
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder |
https://ClinicalTrials.gov/show/NCT03538444 |
Recruiting |
Medical University of South Carolina |
2021-06-01 |
| NCT03155906 |
Integrated Treatment of Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT03155906 |
Active, not recruiting |
Haukeland University Hospital |
2020-05-08 |
| NCT03022890 |
Study of Yoga vs. Health Education for Chronic Pain in Persons Receiving Opioid Agonist Therapy |
https://ClinicalTrials.gov/show/NCT03022890 |
Completed |
Butler Hospital |
2018-11-16 |
| NCT02992938 |
Administration of Acetazolamide to Prevent Remifentanil Induced Hyperalgesia |
https://ClinicalTrials.gov/show/NCT02992938 |
Completed |
University of Chile |
2018-09-28 |
| NCT02617628 |
Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone |
https://ClinicalTrials.gov/show/NCT02617628 |
Completed |
University of Pennsylvania |
2018-12-31 |
| NCT02737696 |
Computer-based Prescription Opioid Abuse Prevention for Adolescents |
https://ClinicalTrials.gov/show/NCT02737696 |
Completed |
Dartmouth-Hitchcock Medical Center |
2018-03-18 |
| NCT03833245 |
Optimizing Pregnancy and Treatment Interventions for Moms 2.0 |
https://ClinicalTrials.gov/show/NCT03833245 |
Recruiting |
University of Utah |
2022-02-28 |
| NCT03610672 |
Mobile Intervention for Young Opioid Users |
https://ClinicalTrials.gov/show/NCT03610672 |
Recruiting |
National Development and Research Institutes, Inc. |
2019-11-28 |
| NCT03527485 |
Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET |
https://ClinicalTrials.gov/show/NCT03527485 |
Active, not recruiting |
Yale University |
2023-12-31 |
| NCT00781898 |
Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site |
https://ClinicalTrials.gov/show/NCT00781898 |
Completed |
University of Pennsylvania |
2015-08-31 |
| NCT00780702 |
Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients |
https://ClinicalTrials.gov/show/NCT00780702 |
Completed |
National Institutes of Health Clinical Center (CC) |
2013-04-16 |
| NCT00763958 |
Relapse Prevention to Reduce HIV Among Women Prisoners |
https://ClinicalTrials.gov/show/NCT00763958 |
Completed |
University of Alabama at Birmingham |
2009-09-30 |
| NCT00757744 |
Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China |
https://ClinicalTrials.gov/show/NCT00757744 |
Completed |
Yale University |
2010-01-31 |
| NCT00756990 |
Depot Naltrexone Treatment of Opioid Dependent Parolees |
https://ClinicalTrials.gov/show/NCT00756990 |
Completed |
University of Pennsylvania |
2009-03-31 |
| NCT00734461 |
Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse |
https://ClinicalTrials.gov/show/NCT00734461 |
Completed |
PainT |
2009-03-31 |
| NCT00733239 |
Drug Discrimination in Methadone-Maintained Humans Study 2 |
https://ClinicalTrials.gov/show/NCT00733239 |
Completed |
University of Arkansas |
2010-10-31 |
| NCT00727675 |
Chronic Pain and Opioid Dependence Assessment and Treatment |
https://ClinicalTrials.gov/show/NCT00727675 |
Completed |
Yale University |
2014-07-31 |
| NCT00723177 |
Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid Withdrawal |
https://ClinicalTrials.gov/show/NCT00723177 |
Completed |
New York State Psychiatric Institute |
2010-04-30 |
| NCT00719095 |
Effective Treatment for Prescription Opioid Abuse |
https://ClinicalTrials.gov/show/NCT00719095 |
Completed |
University of Vermont Medical Center |
2010-03-31 |
| NCT00718835 |
Incentive-based Smoking Cessation for Methadone Patients |
https://ClinicalTrials.gov/show/NCT00718835 |
Completed |
University of Vermont Medical Center |
2013-06-30 |
| NCT00712036 |
Entry Into Comprehensive Methadone Treatment Via Interim Maintenance |
https://ClinicalTrials.gov/show/NCT00712036 |
Completed |
Friends Research Institute, Inc. |
2011-01-31 |
| NCT00710385 |
Abuse Liability of Suboxone Versus Subutex |
https://ClinicalTrials.gov/show/NCT00710385 |
Completed |
New York State Psychiatric Institute |
2008-08-31 |
| NCT00699010 |
Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse |
https://ClinicalTrials.gov/show/NCT00699010 |
Completed |
Acura Pharmaceuticals Inc. |
2008-08-31 |
| NCT00684788 |
Employment-Based Depot Naltrexone Clinical Trial |
https://ClinicalTrials.gov/show/NCT00684788 |
Completed |
Johns Hopkins University |
2009-05-31 |
| NCT00684775 |
Employment-Based Depot Naltrexone Clinical Trial II |
https://ClinicalTrials.gov/show/NCT00684775 |
Completed |
Johns Hopkins University |
2010-04-30 |
| NCT00684554 |
Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial |
https://ClinicalTrials.gov/show/NCT00684554 |
Completed |
New York State Psychiatric Institute |
2008-08-31 |
| NCT00684073 |
Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00684073 |
Completed |
Indivior Inc. |
2007-12-31 |
| NCT00678418 |
ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence |
https://ClinicalTrials.gov/show/NCT00678418 |
Completed |
Alkermes, Inc. |
2009-10-31 |
| NCT00640835 |
Safety and Tolerability of Buprenorphine/Naloxone Film Strips |
https://ClinicalTrials.gov/show/NCT00640835 |
Completed |
Indivior Inc. |
2008-10-31 |
| NCT00637000 |
Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone |
https://ClinicalTrials.gov/show/NCT00637000 |
Completed |
Indivior Inc. |
2008-09-30 |
| NCT00633243 |
Effective Treatment of Hepatitis C in Substance Users |
https://ClinicalTrials.gov/show/NCT00633243 |
Completed |
Yale University |
2011-09-30 |
| NCT00630201 |
Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence |
https://ClinicalTrials.gov/show/NCT00630201 |
Completed |
Titan Pharmaceuticals |
2009-02-28 |
| NCT00622596 |
Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance |
https://ClinicalTrials.gov/show/NCT00622596 |
Completed |
Yale University |
2008-09-30 |
| NCT00605033 |
A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00605033 |
Completed |
Indivior Inc. |
2009-04-30 |
| NCT00604188 |
A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00604188 |
Completed |
Merck Sharp & Dohme Corp. |
2009-12-10 |
| NCT00595764 |
Counseling for Primary Care Office-based Buprenorphine |
https://ClinicalTrials.gov/show/NCT00595764 |
Completed |
Yale University |
2011-02-28 |
| NCT00593125 |
Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients. |
https://ClinicalTrials.gov/show/NCT00593125 |
Completed |
National Institute on Drug Abuse (NIDA) |
2007-08-31 |
| NCT00591617 |
Optimizing Outcomes Using Suboxone for Opiate Dependence |
https://ClinicalTrials.gov/show/NCT00591617 |
Completed |
University of California, Los Angeles |
2012-01-31 |
| NCT00580827 |
Clinical Efficacy of Disulfiram in LAAM-Maintained Cocaine Abusers |
https://ClinicalTrials.gov/show/NCT00580827 |
Completed |
Yale University |
2004-03-31 |
| NCT00577408 |
Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone |
https://ClinicalTrials.gov/show/NCT00577408 |
Completed |
New York State Psychiatric Institute |
2011-08-31 |
| NCT00566969 |
Cocaine Withdrawal and Pharmacotherapy Response |
https://ClinicalTrials.gov/show/NCT00566969 |
Completed |
Yale University |
2012-12-31 |
| NCT00555425 |
Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence |
https://ClinicalTrials.gov/show/NCT00555425 |
Completed |
Yale University |
2013-05-31 |
| NCT00548275 |
Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence |
https://ClinicalTrials.gov/show/NCT00548275 |
Completed |
Yale University |
2011-06-30 |
| NCT00521157 |
Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction |
https://ClinicalTrials.gov/show/NCT00521157 |
Completed |
University of Oslo |
2008-06-30 |
| NCT00499746 |
The Discriminative Effects of Tramadol in Humans |
https://ClinicalTrials.gov/show/NCT00499746 |
Completed |
National Institute on Drug Abuse (NIDA) |
2010-04-30 |
| NCT00476242 |
Memantine as a Supplement to Naltrexone in Treating Heroin Dependence |
https://ClinicalTrials.gov/show/NCT00476242 |
Completed |
New York State Psychiatric Institute |
2011-08-31 |
| NCT00475878 |
SSRI and Buprenorphine |
https://ClinicalTrials.gov/show/NCT00475878 |
Completed |
Butler Hospital |
2009-09-30 |
| NCT00460239 |
Buprenorphine’s Dose Response Curve |
https://ClinicalTrials.gov/show/NCT00460239 |
Completed |
Johns Hopkins University |
2009-07-31 |
| NCT00447564 |
Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence |
https://ClinicalTrials.gov/show/NCT00447564 |
Completed |
Titan Pharmaceuticals |
2008-07-31 |
| NCT00439036 |
Acceptance Therapy During Methadone Detoxification |
https://ClinicalTrials.gov/show/NCT00439036 |
Completed |
The University of Texas Health Science Center, Houston |
2010-08-31 |
| NCT00420771 |
Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients |
https://ClinicalTrials.gov/show/NCT00420771 |
Completed |
New York State Psychiatric Institute |
2011-01-31 |
| NCT00367302 |
Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release |
https://ClinicalTrials.gov/show/NCT00367302 |
Completed |
National Development and Research Institutes, Inc. |
2008-01-31 |
| NCT00406484 |
Brief Introductory Therapy for Opioid Dependence |
https://ClinicalTrials.gov/show/NCT00406484 |
Completed |
Yale University |
2009-09-30 |
| NCT00383045 |
HIV Risk Reduction and Drug Abuse Treatment in Malaysia |
https://ClinicalTrials.gov/show/NCT00383045 |
Completed |
Yale University |
NA |
| NCT00367874 |
Treatment of Polydrug-Using Opiate Dependents During Withdrawal |
https://ClinicalTrials.gov/show/NCT00367874 |
Completed |
Sorlandet Hospital HF |
NA |
| NCT00351026 |
Methadone Maintenance & HIV Risk in Ukraine |
https://ClinicalTrials.gov/show/NCT00351026 |
Completed |
University of Pennsylvania |
2010-10-31 |
| NCT00348868 |
Buprenorphine HIV Care Integration Project |
https://ClinicalTrials.gov/show/NCT00348868 |
Completed |
University of Miami |
2007-12-31 |
| NCT00344812 |
Opioid Maintenance Medications Comparison Study |
https://ClinicalTrials.gov/show/NCT00344812 |
Completed |
Johns Hopkins University |
NA |
| NCT00332228 |
Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence |
https://ClinicalTrials.gov/show/NCT00332228 |
Completed |
New York State Psychiatric Institute |
2007-12-31 |
| NCT00316277 |
Prescription Opioid Addiction Treatment Study (POATS) |
https://ClinicalTrials.gov/show/NCT00316277 |
Completed |
Mclean Hospital |
2009-07-31 |
| NCT00301210 |
Assessment of Tramadol as a Treatment for Opioid Addiction |
https://ClinicalTrials.gov/show/NCT00301210 |
Completed |
Johns Hopkins University |
2007-10-31 |
| NCT00300794 |
Effects of Ketamine On Precipitated Opioid Withdrawal Under General Anaesthesia |
https://ClinicalTrials.gov/show/NCT00300794 |
Completed |
Vilnius University |
NA |
| NCT00295308 |
Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients |
https://ClinicalTrials.gov/show/NCT00295308 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00292123 |
Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse |
https://ClinicalTrials.gov/show/NCT00292123 |
Completed |
National Institute on Drug Abuse (NIDA) |
2006-06-30 |
| NCT00268814 |
The German Project of Heroin Assisted Treatment of Opiate Dependent Patients |
https://ClinicalTrials.gov/show/NCT00268814 |
Completed |
Universitätsklinikum Hamburg-Eppendorf |
2003-12-31 |
| NCT00271219 |
RCT Comparing Methadone and Buprenorphine in Pregnant Women |
https://ClinicalTrials.gov/show/NCT00271219 |
Completed |
Johns Hopkins University |
2009-08-31 |
| NCT00263458 |
Integrating Buprenorphine Into the SFGH AIDS Program |
https://ClinicalTrials.gov/show/NCT00263458 |
Completed |
University of California, San Francisco |
2009-06-30 |
| NCT00253890 |
Insomnia and Drug Relapse Risk |
https://ClinicalTrials.gov/show/NCT00253890 |
Completed |
Butler Hospital |
2010-05-31 |
| NCT00249587 |
Medication Adherence Therapy for Opioid Abusing Pain Patients |
https://ClinicalTrials.gov/show/NCT00249587 |
Completed |
National Institute on Drug Abuse (NIDA) |
2005-09-30 |
| NCT00249470 |
The Therapeutic Workplace Initiation Study |
https://ClinicalTrials.gov/show/NCT00249470 |
Completed |
Johns Hopkins University |
2004-05-31 |
| NCT00249457 |
Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2 |
https://ClinicalTrials.gov/show/NCT00249457 |
Completed |
Johns Hopkins University |
2006-01-31 |
| NCT00241943 |
A Video-Based HCV Curriculum for Active Injection Drug Users |
https://ClinicalTrials.gov/show/NCT00241943 |
Completed |
Organization to Achieve Solutions in Substance Abuse (OASIS) |
2007-08-31 |
| NCT00241917 |
A Video-Based HCV Curriculum for Drug Users |
https://ClinicalTrials.gov/show/NCT00241917 |
Completed |
Organization to Achieve Solutions in Substance Abuse (OASIS) |
2007-05-31 |
| NCT00238914 |
Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1 |
https://ClinicalTrials.gov/show/NCT00238914 |
Completed |
New York State Psychiatric Institute |
2002-07-31 |
| NCT00235729 |
Lofexidine for Inpatient Opiate Detox |
https://ClinicalTrials.gov/show/NCT00235729 |
Completed |
VA Office of Research and Development |
2007-10-31 |
| NCT00218608 |
Disulfiram for Treating Cocaine Dependence in Individuals Maintained on Methadone |
https://ClinicalTrials.gov/show/NCT00218608 |
Completed |
University of Arkansas |
2007-01-31 |
| NCT00218426 |
Addiction Treatment in Russia: Oral vs. Naltrexone Implant |
https://ClinicalTrials.gov/show/NCT00218426 |
Completed |
University of Pennsylvania |
2009-06-30 |
| NCT00218374 |
Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia |
https://ClinicalTrials.gov/show/NCT00218374 |
Completed |
National Institute on Drug Abuse (NIDA) |
2007-06-30 |
| NCT00218101 |
Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids |
https://ClinicalTrials.gov/show/NCT00218101 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00204243 |
Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional Services |
https://ClinicalTrials.gov/show/NCT00204243 |
Completed |
University of Oslo |
2008-02-29 |
| NCT00175357 |
NAOMI: A Study to Compare Medically-prescribed Heroin With Oral Methadone in Chronic Opiate Addiction |
https://ClinicalTrials.gov/show/NCT00175357 |
Completed |
University of British Columbia |
2007-04-30 |
| NCT00158288 |
The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1 |
https://ClinicalTrials.gov/show/NCT00158288 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00158236 |
Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users |
https://ClinicalTrials.gov/show/NCT00158236 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00158184 |
Prescription Opioid Effects in Abusers Versus Non-Abusers |
https://ClinicalTrials.gov/show/NCT00158184 |
Completed |
New York State Psychiatric Institute |
2009-06-30 |
| NCT00149669 |
Employment-based Reinforcement of Naltrexone Ingestion and Abstinence |
https://ClinicalTrials.gov/show/NCT00149669 |
Completed |
Johns Hopkins University |
2010-12-31 |
| NCT00149630 |
Pharmacogenetics of Disulfiram for Cocaine |
https://ClinicalTrials.gov/show/NCT00149630 |
Completed |
Baylor College of Medicine |
2009-12-31 |
| NCT00147784 |
HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group. |
https://ClinicalTrials.gov/show/NCT00147784 |
Completed |
Sorlandet Hospital HF |
2007-06-30 |
| NCT00142935 |
Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1 |
https://ClinicalTrials.gov/show/NCT00142935 |
Completed |
The Miriam Hospital |
2009-12-31 |
| NCT00142909 |
Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1 |
https://ClinicalTrials.gov/show/NCT00142909 |
Completed |
Yale University |
2009-01-31 |
| NCT00142896 |
Tramadol to Reduce Opioid Withdrawal Symptoms |
https://ClinicalTrials.gov/show/NCT00142896 |
Completed |
National Institute on Drug Abuse (NIDA) |
2005-12-31 |
| NCT00142779 |
Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts |
https://ClinicalTrials.gov/show/NCT00142779 |
Completed |
National Institute on Drug Abuse (NIDA) |
2006-01-31 |
| NCT00135759 |
Addition of Naltrexone to Methadone Taper |
https://ClinicalTrials.gov/show/NCT00135759 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00134914 |
Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence |
https://ClinicalTrials.gov/show/NCT00134914 |
Completed |
National Institute on Drug Abuse (NIDA) |
1998-04-30 |
| NCT00134888 |
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence |
https://ClinicalTrials.gov/show/NCT00134888 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00130819 |
Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants |
https://ClinicalTrials.gov/show/NCT00130819 |
Completed |
Johns Hopkins University |
2009-04-30 |
| NCT00129298 |
Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1 |
https://ClinicalTrials.gov/show/NCT00129298 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00798538 |
Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM) |
https://ClinicalTrials.gov/show/NCT00798538 |
Completed |
Yale University |
2010-08-31 |
| NCT00125515 |
Memantine and Naltrexone Treatment for Opioid Dependence |
https://ClinicalTrials.gov/show/NCT00125515 |
Completed |
New York State Psychiatric Institute |
2008-08-31 |
| NCT00117741 |
Evaluation of DBT Compared to Drug Counseling for Opiate Addicts |
https://ClinicalTrials.gov/show/NCT00117741 |
Completed |
University of Washington |
2008-10-31 |
| NCT00078130 |
Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1 |
https://ClinicalTrials.gov/show/NCT00078130 |
Completed |
National Institute on Drug Abuse (NIDA) |
2006-01-31 |
| NCT00078117 |
Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1 |
https://ClinicalTrials.gov/show/NCT00078117 |
Completed |
National Institute on Drug Abuse (NIDA) |
2005-05-31 |
| NCT00061100 |
HIV Counseling Intervention for Methadone-Maintained Patients - 2 |
https://ClinicalTrials.gov/show/NCT00061100 |
Completed |
New York State Psychiatric Institute |
2003-10-31 |
| NCT00061087 |
Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1 |
https://ClinicalTrials.gov/show/NCT00061087 |
Completed |
New York State Psychiatric Institute |
2004-10-31 |
| NCT00032942 |
Lofexidine for Opiate Withdrawal - 1 |
https://ClinicalTrials.gov/show/NCT00032942 |
Completed |
National Institute on Drug Abuse (NIDA) |
2004-10-31 |
| NCT00018226 |
Effect Of Case Management Following Discharge From Methadone Treatment |
https://ClinicalTrials.gov/show/NCT00018226 |
Completed |
VA Office of Research and Development |
NA |
| NCT00015340 |
Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14 |
https://ClinicalTrials.gov/show/NCT00015340 |
Completed |
National Institute on Drug Abuse (NIDA) |
2001-08-31 |
| NCT00015288 |
Buprenorphine and Naloxone Combination Study - 10 |
https://ClinicalTrials.gov/show/NCT00015288 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00007527 |
Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice |
https://ClinicalTrials.gov/show/NCT00007527 |
Completed |
VA Office of Research and Development |
NA |
| NCT00000254 |
Isoflurane at Subanesthetic Concentrations - 6 |
https://ClinicalTrials.gov/show/NCT00000254 |
Completed |
University of Chicago |
1995-09-30 |
| NCT00218127 |
Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens |
https://ClinicalTrials.gov/show/NCT00218127 |
Completed |
National Institute on Drug Abuse (NIDA) |
2005-07-31 |
| NCT00000358 |
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7 |
https://ClinicalTrials.gov/show/NCT00000358 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000357 |
Buprenorphine Maintenance for Opiate Dependence - 6 |
https://ClinicalTrials.gov/show/NCT00000357 |
Completed |
National Institute on Drug Abuse (NIDA) |
1993-08-31 |
| NCT00000356 |
Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5 |
https://ClinicalTrials.gov/show/NCT00000356 |
Completed |
National Institute on Drug Abuse (NIDA) |
1992-08-31 |
| NCT00000355 |
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4 |
https://ClinicalTrials.gov/show/NCT00000355 |
Completed |
National Institute on Drug Abuse (NIDA) |
1996-01-31 |
| NCT00000354 |
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3 |
https://ClinicalTrials.gov/show/NCT00000354 |
Completed |
National Institute on Drug Abuse (NIDA) |
1997-09-30 |
| NCT00000353 |
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2 |
https://ClinicalTrials.gov/show/NCT00000353 |
Completed |
National Institute on Drug Abuse (NIDA) |
1997-09-30 |
| NCT00000352 |
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1 |
https://ClinicalTrials.gov/show/NCT00000352 |
Completed |
National Institute on Drug Abuse (NIDA) |
1998-02-28 |
| NCT00000345 |
Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10 |
https://ClinicalTrials.gov/show/NCT00000345 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000344 |
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9 |
https://ClinicalTrials.gov/show/NCT00000344 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000341 |
Evaluation of Liquid vs. Tablet Buprenorphine - 6 |
https://ClinicalTrials.gov/show/NCT00000341 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000335 |
Activity Monitoring Assessment of Opiate Withdrawal - 4 |
https://ClinicalTrials.gov/show/NCT00000335 |
Completed |
National Institute on Drug Abuse (NIDA) |
1996-03-20 |
| NCT00000334 |
Comparison of Buprenorphine and Methadone - 3 |
https://ClinicalTrials.gov/show/NCT00000334 |
Completed |
National Institute on Drug Abuse (NIDA) |
2004-11-01 |
| NCT00000320 |
Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 |
https://ClinicalTrials.gov/show/NCT00000320 |
Completed |
National Institute on Drug Abuse (NIDA) |
1999-08-31 |
| NCT00000318 |
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1 |
https://ClinicalTrials.gov/show/NCT00000318 |
Completed |
National Institute on Drug Abuse (NIDA) |
2004-03-31 |
| NCT00000311 |
Combining Behavioral Treatment With Agonist Maintenance - 1 |
https://ClinicalTrials.gov/show/NCT00000311 |
Completed |
Yale University |
1999-02-28 |
| NCT00000306 |
Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3 |
https://ClinicalTrials.gov/show/NCT00000306 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000300 |
Feasibility Study of Take-Home LAAM Medication - 3 |
https://ClinicalTrials.gov/show/NCT00000300 |
Completed |
University of California, Los Angeles |
NA |
| NCT00000299 |
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2 |
https://ClinicalTrials.gov/show/NCT00000299 |
Completed |
University of California, Los Angeles |
2009-11-30 |
| NCT00000298 |
Buprenorphine Combination Tablet Feasibility - 1 |
https://ClinicalTrials.gov/show/NCT00000298 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000279 |
Novel Medications for Opiate Detoxification - 4 |
https://ClinicalTrials.gov/show/NCT00000279 |
Completed |
Yale University |
1999-08-31 |
| NCT00000273 |
A Laboratory Model for Heroin Abuse Medications - 8 |
https://ClinicalTrials.gov/show/NCT00000273 |
Completed |
New York State Psychiatric Institute |
2005-11-30 |
| NCT00000264 |
Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16 |
https://ClinicalTrials.gov/show/NCT00000264 |
Completed |
University of Chicago |
1999-10-31 |
| NCT00000263 |
Effects of Combined Alcohol and Nitrous Oxide Intake - 15 |
https://ClinicalTrials.gov/show/NCT00000263 |
Completed |
University of Chicago |
1998-10-31 |
| NCT00000262 |
Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14 |
https://ClinicalTrials.gov/show/NCT00000262 |
Completed |
University of Chicago |
1999-02-28 |
| NCT00000261 |
Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13 |
https://ClinicalTrials.gov/show/NCT00000261 |
Completed |
University of Chicago |
1998-10-31 |
| NCT00000260 |
Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12 |
https://ClinicalTrials.gov/show/NCT00000260 |
Completed |
University of Chicago |
1998-01-31 |
| NCT00000259 |
Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11 |
https://ClinicalTrials.gov/show/NCT00000259 |
Completed |
University of Chicago |
1997-11-30 |
| NCT00000258 |
Role of Instructions in Nitrous Oxide Effects and Choice - 10 |
https://ClinicalTrials.gov/show/NCT00000258 |
Completed |
University of Chicago |
1997-11-30 |
| NCT00000257 |
Effects of Alcohol History on Effects of Nitrous Oxide - 9 |
https://ClinicalTrials.gov/show/NCT00000257 |
Completed |
University of Chicago |
1997-04-30 |
| NCT00000256 |
Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8 |
https://ClinicalTrials.gov/show/NCT00000256 |
Completed |
University of Chicago |
1996-11-30 |
| NCT00000255 |
Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7 |
https://ClinicalTrials.gov/show/NCT00000255 |
Completed |
University of Chicago |
1996-05-31 |
| NCT00000253 |
Effects of Nitrous Oxide: A Dose-Response Analysis - 5 |
https://ClinicalTrials.gov/show/NCT00000253 |
Completed |
University of Chicago |
1996-03-31 |
| NCT00000252 |
Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4 |
https://ClinicalTrials.gov/show/NCT00000252 |
Completed |
University of Chicago |
1996-06-30 |
| NCT00000251 |
Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3 |
https://ClinicalTrials.gov/show/NCT00000251 |
Completed |
University of Chicago |
1996-01-31 |
| NCT00000250 |
Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2 |
https://ClinicalTrials.gov/show/NCT00000250 |
Completed |
University of Chicago |
1995-05-31 |
| NCT00000249 |
Effects of Subanesthetic Concentrations of Nitrous Oxide - 1 |
https://ClinicalTrials.gov/show/NCT00000249 |
Completed |
University of Chicago |
1995-06-30 |
| NCT00000244 |
Effects of Dynorphin 1-13 on Heroin Addiction - 1 |
https://ClinicalTrials.gov/show/NCT00000244 |
Completed |
University of Minnesota |
1997-03-31 |
| NCT00000240 |
Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22 |
https://ClinicalTrials.gov/show/NCT00000240 |
Completed |
University of Vermont |
NA |
| NCT00000239 |
Buprenorphine Pharmacology Related to Addiction Treatment - 21 |
https://ClinicalTrials.gov/show/NCT00000239 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000238 |
Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20 |
https://ClinicalTrials.gov/show/NCT00000238 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000237 |
Buprenorphine Detoxification - BBDVI - 19 |
https://ClinicalTrials.gov/show/NCT00000237 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000236 |
Buprenorphine Pharmacology Related to Addiction Treatment - 18 |
https://ClinicalTrials.gov/show/NCT00000236 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000235 |
Alternate Day Buprenorphine Administration, Phase XII - 17 |
https://ClinicalTrials.gov/show/NCT00000235 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000234 |
Alternate Day Buprenorphine Administration, Phase XI - 16 |
https://ClinicalTrials.gov/show/NCT00000234 |
Completed |
University of Vermont |
NA |
| NCT00000233 |
Alternate Day Buprenorphine Administration, Phase X - 15 |
https://ClinicalTrials.gov/show/NCT00000233 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000232 |
Alternate Day Buprenorphine Administration, Phase IX - 14 |
https://ClinicalTrials.gov/show/NCT00000232 |
Completed |
University of Vermont |
NA |
| NCT00000231 |
Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13 |
https://ClinicalTrials.gov/show/NCT00000231 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000230 |
Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12 |
https://ClinicalTrials.gov/show/NCT00000230 |
Completed |
University of Vermont |
NA |
| NCT00000229 |
Buprenorphine Detox With Two Types of Treatment. BBD II - 11 |
https://ClinicalTrials.gov/show/NCT00000229 |
Completed |
University of Vermont |
NA |
| NCT00000228 |
Buprenorphine Detox With Two Types of Treatment. BBD I - 10 |
https://ClinicalTrials.gov/show/NCT00000228 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000227 |
Alternate-Day Buprenorphine Administration. Phase VIII - 9 |
https://ClinicalTrials.gov/show/NCT00000227 |
Completed |
University of Vermont |
NA |
| NCT00000226 |
Alternate-Day Buprenorphine Administration. Phase VII - 8 |
https://ClinicalTrials.gov/show/NCT00000226 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000225 |
Alternate-Day Buprenorphine Administration. Phase VI - 7 |
https://ClinicalTrials.gov/show/NCT00000225 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000224 |
Alternate-Day Buprenorphine. Phase V - 6 |
https://ClinicalTrials.gov/show/NCT00000224 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000223 |
Alternate-Day Buprenorphine Administration. Phase IV - 5 |
https://ClinicalTrials.gov/show/NCT00000223 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000222 |
Alternate-Day Buprenorphine Administration. Phase II - 4 |
https://ClinicalTrials.gov/show/NCT00000222 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000221 |
Alternate-Day Buprenorphine Administration. Phase I - 3 |
https://ClinicalTrials.gov/show/NCT00000221 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000220 |
Gradual Vs. Rapid Buprenorphine Detoxification - 2 |
https://ClinicalTrials.gov/show/NCT00000220 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000219 |
Buprenorphine Dose Alteration Study - 1 |
https://ClinicalTrials.gov/show/NCT00000219 |
Completed |
University of Vermont |
NA |
| NCT00015171 |
Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1 |
https://ClinicalTrials.gov/show/NCT00015171 |
Completed |
National Institute on Drug Abuse (NIDA) |
1997-05-31 |
| NCT00015041 |
Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2 |
https://ClinicalTrials.gov/show/NCT00015041 |
Completed |
National Institute on Drug Abuse (NIDA) |
1998-06-30 |
| NCT00015028 |
Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1 |
https://ClinicalTrials.gov/show/NCT00015028 |
Completed |
National Institute on Drug Abuse (NIDA) |
1996-12-31 |
| NCT00000209 |
Buprenorphine Dosing Interval - 5 |
https://ClinicalTrials.gov/show/NCT00000209 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000208 |
Methadone/Buprenorphine Cross-Over Study - 4 |
https://ClinicalTrials.gov/show/NCT00000208 |
Completed |
National Institute on Drug Abuse (NIDA) |
NA |
| NCT00000207 |
Multicenter Clinical Trial of Buprenorphine - 3 |
https://ClinicalTrials.gov/show/NCT00000207 |
Completed |
University of California, Los Angeles |
1997-04-30 |
| NCT00000206 |
Clinical Rescue Protocol - 2 |
https://ClinicalTrials.gov/show/NCT00000206 |
Completed |
University of California, Los Angeles |
2005-08-31 |
| NCT00000205 |
Buprenorphine Maintenance Protocol - 1 |
https://ClinicalTrials.gov/show/NCT00000205 |
Completed |
University of California, Los Angeles |
1993-03-31 |
| NCT00000204 |
Buprenorphine Maintenance for Opioid Addicts - 3 |
https://ClinicalTrials.gov/show/NCT00000204 |
Completed |
Yale University |
2006-05-31 |
| NCT00000203 |
Buprenorphine Maintenance for Opioid Addicts - 2 |
https://ClinicalTrials.gov/show/NCT00000203 |
Completed |
Yale University |
2006-05-31 |
| NCT00000202 |
Buprenorphine Maintenance for Opioid Addicts - 1 |
https://ClinicalTrials.gov/show/NCT00000202 |
Completed |
Yale University |
2006-05-31 |